HUTCHMED (China) (HCM) Cost of Revenue (2015 - 2021)
HUTCHMED (China)'s (HCM) quarterly Cost of Revenue came in at $101.8 million in Q2 2021, up 25.69% year-on-year from $81.0 million in Q2 2020, and up 1675.3% on a QoQ basis from $5.7 million in Q1 2021.
HUTCHMED (China) (HCM) Cost of Revenue (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Cost of Revenue data on file, last reported at $101.8 million in Q2 2021.
- On a quarterly basis, Cost of Revenue rose 25.69% year-over-year to $101.8 million in Q2 2021; TTM through Jun 2021 was $191.1 million, a 722.04% increase from a year earlier, with the FY2025 full-year figure at $36.3 million, down 25.32% from the prior year.
- Cost of Revenue for Q2 2021 stood at $101.8 million, up from $5.7 million in the prior quarter.
- Over the last five years, Cost of Revenue for HCM reached as high as $101.8 million in Q2 2021 and fell as low as -$62.4 million in Q3 2019.
- Historically, Cost of Revenue has averaged $18.5 million across 4 years, with a median of $4.4 million in 2018.
- On a YoY basis, Cost of Revenue climbed as much as 1370.92% in 2019 and fell as far as 1562.86% in 2019.
- Year by year, Cost of Revenue stood at $4.1 million in 2018, then sank by 49.4% to $2.1 million in 2019, then surged by 3823.35% to $81.0 million in 2020, then gained by 25.69% to $101.8 million in 2021.
- Per Business Quant data, the three most recent Cost of Revenue figures were $101.8 million in Q2 2021, $5.7 million in Q1 2021, and $81.0 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | HUTCHMED (China) | 9.55 Bn | 9.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 101.78 Mn |
| Jun 30, 2021 | 101.78 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Jun 30, 2020 | 80.98 Mn |
| Jun 30, 2020 | 80.98 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Dec 31, 2019 | 2.06 Mn |
| Dec 31, 2019 | 2.06 Mn |
| Sep 30, 2019 | -62.39 Mn |
| Sep 30, 2019 | -62.39 Mn |
| Jun 30, 2019 | 70.27 Mn |
| Jun 30, 2019 | 70.27 Mn |
| Mar 31, 2019 | 3.79 Mn |
| Mar 31, 2019 | 3.79 Mn |
| Dec 31, 2018 | 4.08 Mn |
| Dec 31, 2018 | 4.08 Mn |
| Sep 30, 2018 | 4.27 Mn |
| Sep 30, 2018 | 4.27 Mn |